يعرض 1 - 20 نتائج من 70 نتيجة بحث عن '"Keks N."', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 1
    Electronic Resource

    مصطلحات الفهرس: extrapyramidal symptom/si [Side Effect], extrapyramidal syndrome/si [Side Effect], insomnia/si [Side Effect], mental disease/si [Side Effect], meta analysis (topic), metabolic disorder/si [Side Effect], muscle hypertonia/si [Side Effect], nausea/si [Side Effect], neuroleptic malignant syndrome/si [Side Effect], Parkinson disease/si [Side Effect], partial agonism, pathological gambling/si [Side Effect], pharmacodynamic parameters, pharmacokinetic parameters, priority journal, prolactin blood level, psychopharmacology, psychopharmacotherapy, psychosis/si [Side Effect], randomized controlled trial (topic), review, risk, schizophrenia/dt [Drug Therapy], sedation, side effect/si [Side Effect], somnolence/si [Side Effect], suicidal behavior/si [Side Effect], alpha 1 adrenergic receptor/ec [Endogenous Compound], aripiprazole/ae [Adverse Drug Reaction], aripiprazole/ct [Clinical Trial], aripiprazole/pd [Pharmacology], brexpiprazole/ae [Adverse Drug Reaction], brexpiprazole/ct [Clinical Trial], brexpiprazole/pd [Pharmacology], cariprazine/ae [Adverse Drug Reaction], cariprazine/ct [Clinical Trial], cariprazine/pd [Pharmacology], dopamine 2 receptor/ec [Endogenous Compound], dopamine 2 receptor stimulating agent/ae [Adverse Drug Reaction], dopamine 2 receptor stimulating agent/ct [Clinical Trial], dopamine 2 receptor stimulating agent/cm [Drug Comparison], dopamine 2 receptor stimulating agent/dt [Drug Therapy], dopamine 2 receptor stimulating agent/pk [Pharmacokinetics], dopamine 2 receptor stimulating agent/pd [Pharmacology], dopamine 3 receptor/ec [Endogenous Compound], dopamine 3 receptor stimulating agent/ae [Adverse Drug Reaction], dopamine 3 receptor stimulating agent/ct [Clinical Trial], dopamine 3 receptor stimulating agent/cm [Drug Comparison], dopamine 3 receptor stimulating agent/dt [Drug Therapy], dopamine 3 receptor stimulating agent/pk [Pharmacokinetics], dopamine 3 receptor stimulating agent/pd [Pharmacology], histamine H1 receptor/ec [Endogenous Compound], muscarinic receptor/ec [Endogenous Compound], prolactin, serotonin 1A receptor/ec [Endogenous Compound], serotonin 2A receptor/ec [Endogenous Compound], serotonin 2B receptor/ec [Endogenous Compound], serotonin 2C receptor/ec [Endogenous Compound], human, adverse drug reaction/si [Side Effect], agitation, akathisia/si [Side Effect], anxiety, body weight disorder/si [Side Effect], body weight gain, cardiovascular symptom/si [Side Effect], cognitive defect/si [Side Effect], comparative effectiveness, compulsion/si [Side Effect], drowsiness/si [Side Effect], drug overdose, drug safety, drug tolerability, drug withdrawal, dystonia/si [Side Effect], emotional disorder/si [Side Effect], experience, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29280
    CNS Drugs
    Click here for full text options
    LibKey Link

  2. 2
    Academic Journal
  3. 3
    Academic Journal

    Relation: https://acuresearchbank.acu.edu.au/item/893zq/assessment-of-cognitive-function-in-heart-failure-patients; https://doi.org/10.1016/j.ejcnurse.2005.10.005; Wolfe, R, Worrall-Carter, Linda, Foister, K., Keks, N. and Howe, V. (2006). Assessment of cognitive function in heart failure patients. European Journal of Cardiovascular Nursing. 5(2), pp. 158 - 164. https://doi.org/10.1016/j.ejcnurse.2005.10.005

  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
  10. 10
    Electronic Resource
  11. 11
    Electronic Resource
  12. 12
    Electronic Resource
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20